
Delcath Systems (DCTH) Stock Forecast & Price Target
Delcath Systems (DCTH) Analyst Ratings
Bulls say
Delcath Systems Inc. is projected to increase its total revenues significantly, anticipating a rise from $82.3 million in 2025 to $338.7 million by 2032, indicating robust long-term growth potential. The company has demonstrated consistent quarter-over-quarter growth in HEPZATO-related revenue since its launch, with fourth-quarter 2024 revenues anticipated to reach $13.7 million, reflecting a noteworthy 37% increase from the previous quarter. Additionally, ongoing site activations and expected steady growth in the European market support a strong pipeline, further enhancing the positive outlook for Delcath Systems's financial performance.
Bears say
Delcath Systems has faced persistent financial challenges, including ongoing operational losses and negative cash flows, which raise concerns about its sustainability and ability to fund future growth initiatives. Additionally, the company’s reliance on a single product for revenue generation exposes it to significant risks, particularly in terms of market competition and regulatory scrutiny. The financial reports indicate a lack of diversified revenue streams, contributing to uncertainty regarding the company’s long-term viability and enhancing the negative outlook on its stock.
This aggregate rating is based on analysts' research of Delcath Systems and is not a guaranteed prediction by Public.com or investment advice.
Delcath Systems (DCTH) Analyst Forecast & Price Prediction
Start investing in Delcath Systems (DCTH)
Order type
Buy in
Order amount
Est. shares
0 shares